In the present study, co-expression of PEBP1/STK11 was predominantly negatively correlated with several pro-inflammatory chemokines and immunosuppressive chemokine receptors, while showing positive correlations with anti-inflammatory chemokines in a cancer type dependent manner. Here, STK11 is linked to cancer.